EXCEED THE SPACE PROVIDED. Prepulse inhibition (PPI) of the acoustic startle response in deficient in patients with schizophrenia. In rats, PPI has been used to study the effetcs of drugs that alter brain dopamine (DA) and serotonin (5-HT) neurotransmission, since these systems are implicated in schizophrenia. Corticotropin-releasing factor (CRF) alters brain extracellular concentrations of DA, 5-HT, and norepinephirne (NE), and central administration of CRF has numerous behavioral effects. Preliminary data show that intracerebroventricular (IV) administration of CRF decreases PPI in both Brown Norway (BN) rats, a strain with low basal PPI, and in Wistar-Kyoto (WKY) rats, a strain with relatively high basasl PPI. Experiments are designed to futher study the role of CRF in PPI in BN and WKY rats, and to examine whether the decrease in PPI caused by CRF is dependent on monoamine neurotransmission.
Specific Aim 1 is to eaxmine the effetcs of a range of doses of CRF (ICV) on PPI and startle amplitude, and to examine whether peripheral administration of CRF, which activated the pituitary/adrenal axis, is sufficient to decrese PPI.
Specific Aim 2 is to examine whther administraion of a CRF antagonist (ICV) improves PPI in BN rats, and to examine whether administration of the antagonis, either prior to or following CRF administration, attenuates the effect of CRF on PPI.
Specific Aim 3 is to examine whether selective depletion of the monoamines (DA, 5-HT, or NE), or adminstration of drugs that are antagonists at DA, 5-HT or NE receptors attenuates the decrease in PPI produced by CRF.
Specific Aim 4 is to assess whether repeated CRF (ICV) results in sensitization or desensitization of the CRF-induced decrease in PPI or of the decrese in PPI caasued by adminstration of the dopamine agonists, amhetamine and apomorphine. In addition to examining the effects of each treatment on PPI in both WKY and BN rats, effects of eac tratment and of rat strain on startle amplitude and CRF-induced grooming willl be assessed. In the monoamine depletion studies, levels of DA, 5-HT, and NE in frontal cortex, hippocampus, nucleus accumbens and hypothalamus will be assessed by HPLC. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH065467-03
Application #
6685329
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (01))
Program Officer
Winsky, Lois M
Project Start
2002-12-01
Project End
2006-11-30
Budget Start
2004-12-01
Budget End
2006-11-30
Support Year
3
Fiscal Year
2005
Total Cost
$238,863
Indirect Cost
Name
University of Connecticut
Department
Psychiatry
Type
Schools of Medicine
DUNS #
022254226
City
Farmington
State
CT
Country
United States
Zip Code
06030
Conti, Lisa H (2012) Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains. Neuropharmacology 62:256-63
Sutherland, Jane E; Conti, Lisa H (2011) Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor. Neuropharmacology 60:561-71
Sutherland, Jane E; Burian, Linda C; Covault, Jonathan et al. (2010) The effect of restraint stress on prepulse inhibition and on corticotropin-releasing factor (CRF) and CRF receptor gene expression in Wistar-Kyoto and Brown Norway rats. Pharmacol Biochem Behav 97:227-38
Conti, Lisa H; Sutherland, Jane E; Muhlhauser, Carey M (2009) Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them. Behav Brain Res 200:165-72
Sutherland, Jane E; Page, Michelle E; Conti, Lisa H (2008) The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats. Pharmacol Biochem Behav 89:324-37
Conti, Lisa H; Berridge, Craig W; Tayler, Jane E (2006) Both corticotropin-releasing factor and apomorphine reduce prepulse inhibition following repeated central infusion of corticotropin-releasing factor. Pharmacol Biochem Behav 85:261-72
Conti, Lisa H (2005) Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats. Eur J Pharmacol 507:125-34
Conti, Lisa H; Costill, Jennifer E; Flynn, Sean et al. (2005) Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain. Behav Neurosci 119:1052-60